OncoFirm Scientific Publications
© 2025 OncoFirm Diagnostics Corporation. All Rights Reserved.
Artificial Intelligence–Enabled Multi-Biomarker Blood Tests for Cancer Screening and Clinical Triage Biological Rationale, Computational Architecture, Validation Requirements, and a Translational Framework for Point-of-Care Deployment OncoFirm Diagnostics Scientific AffairsArticle type: Technical…
Laboratory Information System (LIS) Integration for Rapid Point-of-Care Diagnostics Seamless Laboratory Information System (LIS) Integration for Connected Healthcare At OncoFirm™ Diagnostics, we are implementing Laboratory Information System (LIS) integration framework…
Why Early Cancer Detection Matters: The Foundation of Modern Cancer Diagnostics Why Early Detection Matters Early cancer detection is one of the most significant factors influencing patient care, treatment planning,…
OncoFirm Diagnostics | https://oncofirm.com 1. Executive Summary The intersection of artificial intelligence (AI) and biomarker science is revolutionizing early cancer detection. By leveraging AI algorithms to analyze complex biological signals, OncoFirm…
Fluorescent LFA vs Traditional Testing
OncoFirm Diagnostics | https://oncofirm.com 1. Executive Summary Early detection of cancer remains one of the most cost-effective, life-saving interventions in modern medicine. However, millions globally still lack access to timely,…